ZIP4 is a novel molecular marker for glioma

Neuro-Oncology

Volumn 15, Issue 8, 2013, Pages 1008-1016

  Lin, Yi ^a,b,c   Chen, Yong ^d   Wang, Yongzhi ^a,c   Yang, Jingxuan ^a   Zhu, Vivian F ^a   Liu, Yulun ^d   Cui, Xiaobo ^a   Chen, Leon ^a   Yan, Wei ^c   Jiang, Tao ^c   Hergenroeder, Georgene W ^a   Fletcher, Stephen A ^a   Levine, Jonathan M ^e   Kim, Dong H ^a   Tandon, Nitin ^a   Zhu, Jay Jiguang ^a   Li, Min ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b CHINA MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^e TEXAS A AND M UNIVERSITY   (United States)

Author keywords

biomarker; brain tumor; prognosis; survival; zinc transporter; ZIP4

Indexed keywords

MOLECULAR MARKER; TEMOZOLOMIDE; TUMOR MARKER; UNCLASSIFIED DRUG; ZINC EXPORTER PROTEIN 1; ZINC EXPORTER PROTEIN 10; ZINC EXPORTER PROTEIN 2; ZINC EXPORTER PROTEIN 3; ZINC EXPORTER PROTEIN 4-1; ZINC EXPORTER PROTEIN 5; ZINC EXPORTER PROTEIN 6; ZINC EXPORTER PROTEIN 7; ZINC EXPORTER PROTEIN 8; ZINC EXPORTER PROTEIN 9; ZINC IMPORTER PROTEIN 1; ZINC IMPORTER PROTEIN 10; ZINC IMPORTER PROTEIN 11; ZINC IMPORTER PROTEIN 12; ZINC IMPORTER PROTEIN 13; ZINC IMPORTER PROTEIN 14; ZINC IMPORTER PROTEIN 2; ZINC IMPORTER PROTEIN 3; ZINC IMPORTER PROTEIN 4; ZINC IMPORTER PROTEIN 5; ZINC IMPORTER PROTEIN 6; ZINC IMPORTER PROTEIN 7; ZINC IMPORTER PROTEIN 8; ZINC IMPORTER PROTEIN 9; ZINC TRANSPORTER;

ARTICLE; CANCER GRADING; CANCER SURVIVAL; COHORT ANALYSIS; GENE EXPRESSION PROFILING; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR GROWTH;

BIOMARKER; BRAIN TUMOR; PROGNOSIS; SURVIVAL; ZINC TRANSPORTER; ZIP4;

ADULT; BRAIN NEOPLASMS; CATION TRANSPORT PROTEINS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84880646695     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not042     Document Type: Article

References (44)

1. Springgate CF, Mildvan AS, Abramson R, Engle JL, Loeb LA. Escherichia coli deoxyribonucleic acid polymerase I, a zinc metalloenzyme. Nuclear quadrupolar relaxation studies of the role of bound zinc. J Biol Chem. 1973;248(17):5987-5993.
2. Tupler R, Perini G, Green MR. Expressing the human genome. Nature. 2001;409(6822):832-833. (Pubitemid 32165335)
3. Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol Rev. 1993;73(1):79-118. (Pubitemid 23065434)
4. Truong-Tran AQ, Carter J, Ruffin RE, Zalewski PD. The role of zinc in caspase activation and apoptotic cell death. Biometals. 2001;14(3-4):315-330. (Pubitemid 34066635)
5. Murakami M, Hirano T. Intracellular zinc homeostasis and zinc signaling. Cancer Sci. 2008;99(8):1515-1522.
6. Maret W. Molecular aspects of human cellular zinc homeostasis: redox control of zinc potentials and zinc signals. Biometals. 2009;22(1):149-157.
7. Hock A, Demmel U, Schicha H, Kasperek K, Feinendegen LE. Trace element concentration in human brain. Activation analysis of cobalt, iron, rubidium, selenium, zinc, chromium, silver, cesium, antimony and scandium. Brain. 1975;98(1):49-64.
8. Sandstead HH, Frederickson CJ, Penland JG. History of zinc as related to brain function. J Nutr. 2000;130(2S Suppl):496S-502S. (Pubitemid 30073782)
9. Cavdar AO, Arcasoy A, Baycu T, Himmetoglu O. Zinc deficiency and an-encephaly in Turkey. Teratology. 1980;22(1):141.
10. Fosmire GJ, al-Ubaidi YY, Sandstead HH. Some effects of postnatal zinc deficiency on developing rat brain. Pediatr Res. 1975;9(2):89-93.
11. Sandstead HH, Fosmire GJ, McKenzie JM, Halas ES. Zinc deficiency and brain development in the rat. Fed Proc. 1975;34(1):86-88.
12. Pullen RG, Franklin PA, Hall GH. 65Zn uptake from blood into brainin the rat. J Neurochem. 1991;56(2):485-489. (Pubitemid 21901988)
13. Kozik MB, Maziarz L, Godlewski A. Morphological and histochemical changes occurring in the brain of rats fed large doses of zinc oxide. Folia Histochem Cytochem (Krakow). 1980;18(3):201-206. (Pubitemid 11172167)
14. Wallwork JC, Milne DB, Sims RL, Sandstead HH. Severe zinc deficiency: effects on the distribution of nine elements (potassium, phosphorus, sodium, magnesium, calcium, iron, zinc, copper and manganese) in regions of the rat brain. J Nutr. 1983;113(10):1895-1905. (Pubitemid 14236236)
15. Prohaska JR. Functions of trace elementsin brain metabolism. Physiol Rev. 1987;67(3):858-901. (Pubitemid 17145566)
16. Takeda A, Tamano H, Enomoto S, Oku N. Zinc-65 imaging of rat brain tumors. Cancer Res. 2001;61(13):5065-5069. (Pubitemid 32681536)
17. Lichten LA, Cousins RJ. Mammalian zinc transporters: nutritional and physiologic regulation. Annu Rev Nutr. 2009;29:153-176.
18. Michalczyk AA, Allen J, Blomeley RC, Ackland ML. Constitutive expression of hZnT4 zinc transporter in human breast epithelial cells. Biochem J. 2002;364(Pt 1):105-113. (Pubitemid 34538952)
19. Taylor K, Vichova P, Jordan N, Hiscox S, Hendley R, Nicholson R. ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in anti-hormone resistant breast cancer cells. Endocrinology. 2008;149(10):4912-4920.
20. Li M, Zhang Y, Liu Z, et al. Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogen-esis and progression. Proc Natl Acad Sci USA. 2007;104(47):18636-18641. (Pubitemid 350210749)
21. Emmetsberger J, Mirrione MM, Zhou C, et al. Tissue plasminogen activator alters intracellular sequestration of zinc through interaction with the transporter ZIP4. J Neurosci. 2010;30(19):6538-6547.
22. Lovell MA. A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease. J Alzheimers Dis. 2009;16(3):471-483.
23. Yokel RA. Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration. J Alzheimers Dis. 2006;10(2-3):223-253. (Pubitemid 44763995)
24. Ni H, Jiang YW, Xiao ZJ, Tao LY, Jin MF, Wu XR. Dynamic pattern of gene expression of ZnT-1, ZnT-3 and PRG-1 in rat brain following flurothyl-induced recurrent neonatal seizures. Toxicol Lett. 2010;194(3):86-93.
25. Gaasch JA, Lockman PR, Geldenhuys WJ, Allen DD, Van der Schyf CJ. Brainiron toxicity: differential responsesofastrocytes, neurons, and endothelial cells. Neurochem Res. 2007;32(7):1196-1208. (Pubitemid 46817469)
26. Morris LG, Veeriah S, Chan TA. Genetic determinants at the interface of cancer and neurodegenerative disease. Oncogene. 2010;29(24):3453-3464.
27. Wessels PH, Weber WE, Raven G, Ramaekers FC, Hopman AH, Twijnstra A. Supratentorial grade II astrocytoma: biological features and clinical course. Lancet Neurol. 2003;2(7):395-403. (Pubitemid 36793931)
28. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996. (Pubitemid 40349501)
29. Zhang Y, Chen C, Yao Q, Li M. ZIP4 upregulates the expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenografts. Cancer Biol Ther. 2010;9(3):235-241.
30. Zhang Y, Bharadwaj U, Logsdon CD, Chen C, Yao Q, Li M. ZIP4 Regulates Pancreatic Cancer Cell Growth by Activating IL-6/STAT3 Pathway through Zinc Finger Transcription Factor CREB. Clin Cancer Res. 2010;16(5):1423-1430.
31. Lonnerdal B. Trace element transport in the mammary gland. Annu Rev Nutr. 2007;27:165-177. (Pubitemid 351373353)
32. Kury S, Dreno B, Bezieau S, et al. Identification of SLC39A4, a gene involvedin acrodermatitis enteropathica. Nat Genet. 2002;31(3):239-240.
33. Ohlsson A. Acrodermatitis enteropathica Reversibility of cerebral atrophy with zinc therapy. Acta Paediatr Scand. 1981;70(2):269-273. (Pubitemid 11184398)
34. Li M, Zhang Y, Bharadwaj U, et al. Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts. Clin Cancer Res. 2009;15(19):5993-6001.
35. Snyder JM, Shofer FS, Van Winkle TJ, Massicotte C. Canine intracranial primary neoplasia: 173 cases (1986-2003). J Vet Intern Med. 2006;20(3):669-675. (Pubitemid 43774117)
36. Lipsitz D, Higgins RJ, Kortz GD, et al. Glioblastoma multiforme: clinical findings, magnetic resonance imaging, and pathology in five dogs. Vet Pathol. 2003;40(6):659-669. (Pubitemid 38393539)
37. Stoica G, Kim HT, Hall DG, Coates JR. Morphology, immunohistochemistry, and genetic alterations in dog astrocytomas. Vet Pathol. 2004;41(1):10-19. (Pubitemid 38146842)
38. Higgins RJ, Dickinson PJ, LeCouteur RA, et al. Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping. J Neurooncol. 2010;98(1):49-55.
39. Toyonaga T, Nakano K, Nagano M, et al. Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer. Cancer Lett. 2003;201(1):107-116. (Pubitemid 37298003)
40. Reardon DA, Wen PY, Desjardins A, Batchelor TT, Vredenburgh JJ. Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy. Expert Opin Biol Ther. 2008;8(4):541-553. (Pubitemid 351570416)
41. Calzolari F, Malatesta P. Recent insights into PDGF-induced gliomagene-sis. Brain Pathol. 2010;20(3):527-538.
42. Wang H, Lathia JD, Wu Q, et al. Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells. 2009;27(10):2393-2404.
43. Carlsson A, Persson O, Ingvarsson J, et al. Plasma proteome profiling reveals biomarker patterns associated with prognosis and therapy selection in glioblastoma multiforme patients. Proteomics Clin Appl. 2010;4(6-7):591-602.
44. Wang H, Shen W, Huang H, et al. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res. 2003;63(15):4315-4321. (Pubitemid 36950996)